Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 12,181
Change Today -46.00 / -0.38%
Volume 488.9K
As of 9:44 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

mediclinic international ltd (MDC) Snapshot

Open
$12,245
Previous Close
$12,227
Day High
$12,345
Day Low
$12,115
52 Week High
04/23/15 - $13,459
52 Week Low
05/5/14 - $7,206
Market Cap
105.7B
Average Volume 10 Days
1.2M
EPS TTM
$4.30
Shares Outstanding
868.0M
EX-Date
12/1/14
P/E TM
28.3x
Dividend
$99.00
Dividend Yield
0.81%
Current Stock Chart for MEDICLINIC INTERNATIONAL LTD (MDC)

Related News

No related news articles were found.

mediclinic international ltd (MDC) Related Businessweek News

No Related Businessweek News Found

mediclinic international ltd (MDC) Details

Mediclinic International Limited, together with its subsidiaries, operates private hospitals in South Africa, Namibia, Switzerland, and the United Arab Emirates. The company offers acute care multidisciplinary hospital and related services under the Mediclinic and Hirslanden brand names. It operates 49 private hospitals in South Africa and 3 in Namibia with 7,614 beds; 14 private hospitals with 1,567 beds in Switzerland; and 2 hospitals with 382 beds and 8 clinics in Dubai in the United Arab Emirates. The company was formerly known as Medi-Clinic Corporation Limited and changed its name to Mediclinic International Limited in September 2011. Mediclinic International Limited was founded in 1983 and is headquartered in Stellenbosch, South Africa.

26,076 Employees
Last Reported Date: 06/24/14
Founded in 1983

mediclinic international ltd (MDC) Top Compensated Officers

Chief Executive Officer, Executive Director, ...
Total Annual Compensation: R9.0M
Chief Financial Officer and Executive Directo...
Total Annual Compensation: R7.0M
Executive Director, Member of Investment Sub-...
Total Annual Compensation: R10.9M
Chief Executive Officer of Mediclinic Middle ...
Total Annual Compensation: R6.3M
Executive Director, Member of Investment Sub-...
Total Annual Compensation: R5.5M
Compensation as of Fiscal Year 2014.

mediclinic international ltd (MDC) Key Developments

Mediclinic International Limited - Analyst/Investor Day

To discuss financial and operational overview of the company's operations in Switzerland

Mediclinic International Limited Announces Unaudited Consolidated Financial Results for the Six Months Ended September 30, 2014; Provides Earnings Guidance for the Current Financial Year 2014

Mediclinic International Limited announced unaudited consolidated financial results for the six months ended September 30, 2014. For the period, the company reported revenue of ZAR 16,828 million against ZAR 14,128 million a year ago. Operating profit before depreciation (ebitda) was ZAR 3,460 million against ZAR 3,044 million a year ago. Operating profit was ZAR 2,737 million against ZAR 2,470 million a year ago. Profit before tax was ZAR 2,217 million against ZAR 1,898 million a year ago. Profit attributable to equity holders of the company was ZAR 1,668 million or 198.8 cents per share against ZAR 1,404 million or 169.2 cents per diluted share a year ago. Diluted headline earnings basis was 185.3 cents against 168.9 cents a year ago. Normalised diluted headline earnings basis was 181.5 cents against 148.1 cents a year ago. Headline earnings was ZAR 1,555 million against ZAR 1,401 million a year ago. Normalized headline earnings was ZAR 1,523 million against ZAR 1,229 million a year ago. Cash flow from operating activities was ZAR 2,726 million against ZAR 2,134 million a year ago. Investment to maintain operations was ZAR 377 million against ZAR 426 million a year ago. Investment to expand operations was ZAR 2,151 million against ZAR 737 million a year ago. Normalised EBITDA was ZAR 3,329 million against ZAR 2,829 million a year ago. For the current financial year 2014, AED 177 million is budgeted for capital projects and new equipment to enhance the business in the longer term, AED15 million for the replacement of existing equipment and AED 20 million for repairs and maintenance. EBITDA resulting from capital projects in progress or approved is budgeted to amount to AED 4 million.

Mediclinic International Limited Declares an Interim Gross Cash Dividend, Payable on December 8, 2014

The board of directors of Mediclinic International Limited declared an interim gross cash dividend in respect of the period under review of 31.0 cents per ordinary share, an increase of 11%. The dividend is payable on December 8, 2014 to the shareholders of record date on December 5, 2014. The Ex-dividend date is December 1, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDC:SJ 12,181.00 -46.00

MDC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDC.
View Industry Companies
 

Industry Analysis

MDC

Industry Average

Valuation MDC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICLINIC INTERNATIONAL LTD, please visit www.mediclinic.co.za. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.